Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Leukoc Biol ; 97(2): 413-24, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25395300

ABSTRACT

Although corneal allotransplantation is performed in the immune-privileged cornea, many grafts are still rejected after transplantation. This study examined the role of chemokine receptor D6 expression in a corneal allograft rejection, investigated the modulation of D6 expression in cells, and determined the effect of D6 on graft survival. Interestingly, D6 was highly expressed in CD45 -: cells and the corneal epithelium of accepted corneal allografts. From the mouse corneal allograft model, TGF-ß was found to play a key role in D6 up-regulation, leading to reduced CCL2, CCL5, and CCL3. To modulate D6 chemokine binding, a D6MT was developed and showed effective chemokine trapping through SPR and FACS assays. By treating corneal allografts with D6MT, the allograft survival rate was improved, and (lymph) angiogenesis was reduced. Direct allosensitization and DC LN homing was drastically reduced in the mouse corneal allograft model. These findings suggest that TGF-ß is a positive regulator of D6 expression, and it is a potential therapeutic target to enhance the survival of corneal allografts.


Subject(s)
Biomimetic Materials/pharmacology , Corneal Transplantation , Gene Expression Regulation/drug effects , Graft Survival/drug effects , Receptors, Chemokine , Allografts , Animals , Chemokine CCL2/immunology , Chemokine CCL3/immunology , Chemokine CCL5/immunology , Gene Expression Regulation/immunology , Graft Survival/immunology , Male , Mice , Transforming Growth Factor beta/immunology
2.
Invest Ophthalmol Vis Sci ; 54(12): 7557-66, 2013 Nov 15.
Article in English | MEDLINE | ID: mdl-24052636

ABSTRACT

PURPOSE: The purpose of this study was to investigate the effectiveness of tumor necrosis factor (TNF)-α blocker for treatment of dry eye (DE)-induced inflammation and determine a more effective method to suppress lacrimal gland inflammation. Efficacy of topical versus systemic administration of TNF-α blockers was determined using a murine dry eye (DE) model. METHODS: The TNF-α blocker HL036 was developed by modification of the TNF receptor I. Protein purity, binding affinity, and clearance of TNF-α was compared with etanercept. Using DE-induced C57BL/6 mice, corneal erosion and goblet cell counts were measured after subcutaneous or topical treatment with etanercept or HL036. Inflammatory cytokines in cornea and lacrimal glands were determined by quantitative RT-PCR and ELISA. RESULTS: HL036 showed TNF-α binding affinity comparable to etanercept, as measured by surface plasmon resonance. HL036 concentration was significantly higher in cornea and anterior segment than etanercept and effectively eliminated TNF-α on ocular surfaces. Etanercept was preferentially concentrated in the posterior segment. Corneal erosion and goblet cell counts were improved only with topically applied etanercept and HL036. Ocular surface IFN-γ, IL-6, and IL-21 were significantly decreased by topical HL036. DE-induced lacrimal gland IFN-γ and IL-6 expression was effectively suppressed by topical etanercept and HL036. CONCLUSIONS: Topical TNF-α blockers effectively suppressed lacrimal gland and corneal inflammation by suppressing IFN-γ, IL-21, and IL-6. Differences in TNF-α affinity, clearance, and local concentration of blockers may account for the anti-inflammatory effects in different ocular regions.


Subject(s)
Dacryocystitis/drug therapy , Disease Models, Animal , Keratitis/drug therapy , Keratoconjunctivitis Sicca/complications , Receptors, Tumor Necrosis Factor, Type I/pharmacology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Animals , Cell Count , Cornea/metabolism , Cytokines/metabolism , Dacryocystitis/etiology , Dacryocystitis/metabolism , Enzyme-Linked Immunosorbent Assay , Etanercept , Female , Goblet Cells/pathology , Immunoglobulin G/pharmacology , Keratitis/etiology , Keratitis/metabolism , Lacrimal Apparatus/metabolism , Mice , Mice, Inbred C57BL , Real-Time Polymerase Chain Reaction , Receptors, Tumor Necrosis Factor
3.
Korean J Physiol Pharmacol ; 15(3): 149-56, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21860593

ABSTRACT

Golgi SNAP receptor complex 1 (GS28) has been implicated in vesicular transport between intra-Golgi networks and between endoplasmic reticulum (ER) and Golgi. Additional role(s) of GS28 within cells have not been well characterized. We observed decreased expression of GS28 in rat ischemic hippocampus. In this study, we examined the role of GS28 and its molecular mechanisms in neuronal (SK-N-SH) cell death induced by hydrogen peroxide (H(2)O(2)). GS28 siRNA-transfected cells treated with H(2)O(2) showed a significant increase in cytotoxicity under glutathione (GSH)-depleted conditions after pretreatment with buthionine sulfoximine, which corresponded to an increase of intracellular reactive oxygen species (ROS) in the cells. Pretreatment of GS28 siRNA-transfected cells with p38 chemical inhibitor significantly inhibited cytotoxicity; we also observed that p38 was activated in the cells by immunoblot analysis. We confirmed the role of p38 MAPK in cotransfected cells with GS28 siRNA and p38 siRNA in the cell viability assay, flow cytometry, and immunoblot. Involvement of apoptotic or autophagic processes in the cells was not shown in the cell viability, flow cytometry, and immunoblot analyses. However, pretreatment of the cells with necrostatin-1 completely inhibited H(2)O(2)-induced cytotoxicity, ROS generation, and p38 activation, indicating that the cell death is necroptotic. Collectively these data imply that H(2)O(2) induces necroptotic cell death in the GS28 siRNA-transfected cells and that the necroptotic signals are mediated by sequential activations in RIP1/p38/ROS. Taken together, these results indicate that GS28 has a protective role in H(2)O(2)-induced necroptosis via inhibition of p38 MAPK in GSH-depleted neuronal cells.

4.
J Cell Biochem ; 112(8): 1985-96, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21433058

ABSTRACT

We examined the role of the c subunit (ATP6L) of vacuolar H(+) -ATPase and its molecular mechanisms in glial cell death induced by sodium nitroprusside (SNP). ATP6L siRNA-transfected cells treated with SNP showed a significant increase in cytotoxicity under glutathione (GSH)-depleted conditions after pretreatment with buthionine sulfoximine, but reduction of ATP6L did not affect the regulation of lysosomal pH in analyses with lysosomal pH-dependent fluorescence probes. Photodegraded SNP and ferrous sulfate induced cytotoxicity with the same pattern as that of SNP, but SNAP and potassium cyanide did not show activity. Pretreatment of the transfected cells with deferoxamine (DFO) reduced ROS production and significantly inhibited the cytotoxicity, which indicates that primarily iron rather than nitric oxide or cyanide from SNP contributes to cell death. Involvement of apoptotic processes in the cells was not shown. Pretreatment with JNK or p38 chemical inhibitor significantly inhibited the cytotoxicity, and we also confirmed that the MAPKs were activated in the cells by immunoblot analysis. Significant increase of LC3-II conversion was observed in the cells, and the conversions were inhibited by cotransfection of the MAPK siRNAs and pretreatment with DFO. Introduction of Atg5 siRNA inhibited the cytotoxicity and inhibited the activation of MAPKs and the conversion of LC3. We finally confirmed autophagic cell death and involvement of MAPKs by observation of autophagic vacuoles via electron microscopy. These data suggest that ATP6L has a protective role against SNP-induced autophagic cell death via inhibition of JNK and p38 in GSH-depleted glial cells.


Subject(s)
Autophagy/drug effects , Glutathione , Neuroglia/enzymology , Nitric Oxide Donors/pharmacology , Nitroprusside/pharmacology , Vacuolar Proton-Translocating ATPases/metabolism , Autophagy/genetics , Buthionine Sulfoximine/pharmacology , Cell Line, Tumor , Enzyme Activation/drug effects , Enzyme Activation/genetics , Humans , Hydrogen-Ion Concentration , Lysosomes/enzymology , Lysosomes/ultrastructure , Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinase Kinases/genetics , Mitogen-Activated Protein Kinase Kinases/metabolism , Neuroglia/ultrastructure , Oxidation-Reduction/drug effects , Protein Kinase Inhibitors/pharmacology , RNA, Small Interfering/genetics , Reactive Oxygen Species/metabolism , Vacuolar Proton-Translocating ATPases/antagonists & inhibitors , Vacuolar Proton-Translocating ATPases/genetics
5.
Free Radic Res ; 45(4): 389-99, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21067284

ABSTRACT

A novel mechanism for H2O2-induced autophagic cell death in GSH-depleted RAW 264.7 cells, a murine macrophage cell line, is proposed. Under GSH-depleted conditions, H2O2-induced autophagic cell, characterized by an increased LC3-II/I ratio, a decreased level of p62 and the formation of autophagic vacuoles, was inhibited by bafilomycin A1 and by Atg5 siRNA transfection, whereas the cell death was not inhibited by zVAD-fmk, by PI3K inhibitors or by Beclin 1 siRNA transfection. In addition, H2O2 treatment reduced the activity of mTOR and promoted the ubiquitination and degradation of Rheb, a key upstream activator of mTOR. Furthermore, proteasome inhibition with MG132 restored the expression of Rheb and increased mTOR activity, resulting in an increased viability of H2O2-treated cells. Collectively, these findings demonstrate that H2O2 induces Beclin 1-independent autophagic cell death by suppressing the mTOR pathway via promoting the ubiquitination and degradation of Rheb in GSH-depleted RAW 264.7 cells.


Subject(s)
Autophagy/drug effects , Glutathione/deficiency , Hydrogen Peroxide/pharmacology , Monomeric GTP-Binding Proteins/metabolism , Neuropeptides/metabolism , Signal Transduction/drug effects , TOR Serine-Threonine Kinases/antagonists & inhibitors , Amino Acid Chloromethyl Ketones/pharmacology , Animals , Apoptosis Regulatory Proteins/metabolism , Autophagy-Related Protein 5 , Beclin-1 , Blotting, Western , Cell Line, Tumor , Cell Survival/drug effects , Enzyme Inhibitors/pharmacology , Gene Expression Regulation , Hydrogen Peroxide/metabolism , Lysosomes/metabolism , Macrolides/pharmacology , Macrophages/cytology , Macrophages/metabolism , Mice , Microtubule-Associated Proteins/metabolism , Monomeric GTP-Binding Proteins/genetics , Neuropeptides/genetics , Proteasome Endopeptidase Complex/metabolism , RNA, Small Interfering/metabolism , Ras Homolog Enriched in Brain Protein , TOR Serine-Threonine Kinases/metabolism , Transcription Factor TFIIH , Transcription Factors/metabolism , Ubiquitination/drug effects
6.
J Biochem Mol Toxicol ; 24(5): 313-22, 2010.
Article in English | MEDLINE | ID: mdl-20201107

ABSTRACT

Previous studies reported that high levels of nitric oxide (NO) induce apoptotic cell death in osteoblasts. We examined molecular mechanisms of cytotoxic injury induced by sodium nitroprusside (SNP), a NO donor, in both glutathione (GSH)-depleted and control U2-OS osteoblasts. Cell viability was reduced by much lower effective concentrations of SNP in GSH-depleted cells compared to normal cells. The data suggest that the level of intracellular GSH is critical in SNP-induced cell death processes of osteoblasts. The level of oxidative stress due to SNP treatments doubled in GSH-depleted cells when measured with fluorochrome H2DCFDA. Pretreatment with the NO scavenger PTIO preserved the viability of cells treated with SNP. Viability of cells treated with SNP was recovered by pretreatment with Wortmannin, an autophagy inhibitor, but not by pretreatment with zVAD-fmk, a pan-specific caspase inhibitor. Large increases of LC3-II were shown by immunoblot analysis of the SNP-treated cells, and the increase was blocked by pretreatment with PTIO or Wortmannin; this implies that under GSH-depleted conditions SNP induces different molecular signaling that lead to autophagic cell death. The ultrastructural morphology of SNP-treated cells in transmission electron microscopy showed numerous autophagic vacuoles. These data suggest NO produces oxidative stress and cellular damage that culminate in autophagic cell death of GSH-depleted osteoblasts.


Subject(s)
Glutathione/metabolism , Nitroprusside/toxicity , Osteoblasts/cytology , Osteoblasts/physiology , Amino Acid Chloromethyl Ketones/metabolism , Apoptosis/physiology , Autophagy/physiology , Cell Death/physiology , Cell Line, Tumor , Cell Survival/physiology , Cells, Cultured , Humans , Nitric Oxide/metabolism , Nitric Oxide Donors , Osteoblasts/ultrastructure , Oxidative Stress/physiology , Sarcoma , Tetrazolium Salts/metabolism , Thiazoles/metabolism
7.
Neurosci Lett ; 461(2): 131-5, 2009 Sep 18.
Article in English | MEDLINE | ID: mdl-19539716

ABSTRACT

Oxidative stress by exposure to H(2)O(2) induces various types of cell death depending on cell type and conditions. We report herein on a study of the mechanisms underlying H(2)O(2)-induced cell death in C6 glioma cells. The findings show that H(2)O(2) triggers a caspase-independent autophagic cell death in these cells. The findings also show that H(2)O(2) induces the dephosphorylation of the mammalian target of rapamycin (mTOR) at Ser 2481 and the p70 ribosomal protein S6 kinase (p70S6K) at Thr389 in a Bcl-2/E1B 19kDa interacting protein 3 (BNIP3)-dependent manner. BNIP3 has the capacity to inhibit mTOR activity and mTOR inhibition plays a role in autophagic induction. This suggests that BNIP3 may mediate H(2)O(2)-induced autophagic cell death through the suppression of mTOR. The findings show that the down-regulation of BNIP3 by BNIP3 siRNA prevents C6 cells from undergoing H(2)O(2)-induced autophagic cell death. Collectively, these results suggest that H(2)O(2) induces autophagic cell death in C6 cells via the BNIP3-mediated suppression of the mTOR pathway.


Subject(s)
Autophagy , Hydrogen Peroxide/pharmacology , Membrane Proteins/physiology , Oxidative Stress , Protein Kinases/physiology , Proto-Oncogene Proteins/physiology , Animals , Cell Line, Tumor , Glioma , Mitochondrial Proteins , Phosphorylation , Rats , Ribosomal Protein S6 Kinases, 70-kDa/metabolism , Signal Transduction , TOR Serine-Threonine Kinases
8.
Neurosci Lett ; 425(3): 183-7, 2007 Oct 02.
Article in English | MEDLINE | ID: mdl-17845832

ABSTRACT

We have isolated a gene, the c subunit (ATP6L) of vacuolar H(+)-ATPase, involved in oxidative stress response. In this study, we examined the role of ATP6L and its molecular mechanisms in glial cell death induced by H(2)O(2). Expression of the ATP6L gene was increased by H(2)O(2) treatment in C6 glial cells. ATP6L siRNA-transfected C6 cells treated with H(2)O(2) showed a significant decrease in viability. ATP6L siRNA-transfected cells that were pretreated with MEK1/2 inhibitor completely recovered cell viability. Pretreatment of the transfected cells with zVAD-fmk, a pan-specific caspase inhibitor, did not result in the recovery of cell viability, as determined by a H(2)O(2)-induced cytotoxicity assay. The ultrastructural morphology of the transfected cells as seen by the use of transmission electron microscopy showed numerous cytoplasmic autophagic vacuoles with double membrane. These results suggest that ATP6L has a protective role against H(2)O(2)-induced cytotoxicity via an inhibition of the Erk1/2 signaling pathway, leading to inhibition of autophagic cell death.


Subject(s)
Brain/enzymology , Hydrogen Peroxide/toxicity , Neuroglia/enzymology , Oxidative Stress/physiology , Vacuolar Proton-Translocating ATPases/metabolism , Animals , Autophagy/drug effects , Autophagy/physiology , Brain/physiopathology , Cell Death/drug effects , Cell Death/physiology , Cell Line, Tumor , Cell Survival/drug effects , Cell Survival/physiology , Cytoprotection/drug effects , Cytoprotection/physiology , Enzyme Inhibitors/pharmacology , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Extracellular Signal-Regulated MAP Kinases/metabolism , Glioma , MAP Kinase Kinase 1/antagonists & inhibitors , MAP Kinase Kinase 1/metabolism , Microscopy, Electron, Transmission , Neuroglia/drug effects , Oxidants/toxicity , Oxidative Stress/drug effects , Protein Subunits/genetics , Protein Subunits/metabolism , RNA, Small Interfering , Rats , Transfection , Vacuolar Proton-Translocating ATPases/genetics , Vacuoles/enzymology , Vacuoles/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL